Fig. 7From: Emerging biomaterials for tumor immunotherapySchematic diagram of silicon NPs based biomaterials for tumor immunotherapy. A Schematic illustration of the preparation of ZnPP@MSN-RGDyK or Z@M-R and their immunotherapy NSCLC-SM. B Therapeutic effect of Z@M-R NPs on the NSCLC-SM. (a) Schedule of NSCLC-SM treatment. (b) Bioluminescence images and (c) statistical analysis of tumorigenesis. (d) Weight change curve. (e) Survival curve. (f) Paralysis curve. (Reproduced with permission from [84] Copyright © 2022, Wiley‐VCH GmbH)Back to article page